Assessment of a Sonic Toothbrush on the Abrasion of the Gingival Tissue
ASTA
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a randomized, monocentric, examiner-blind, two-arm, parallel, controlled clinical research study. It aims to assess gingival abrasion by the comparison of pre- to- post-brushing after a single brushing and after 12 weeks of daily home brushing using a macro-relief scoring based on photographs of the gingiva. The study also aims to assess plaque removal, gingival inflammation, gingival recession and gingival color after 12 weeks. To enter the study, adult male and female subjects attending the service of odontology at Rothschild hospital (Paris, France) will refrain from all oral hygiene procedures for 24 hours. Subjects will have the study procedure explained to them both orally and by written instructions. Eligible patients will give their written consent to participate before being included into the study. Following a baseline clinical examination for collection of the following periodontal parameters: plaque control record (PCR), bleeding on probing (BOP), gingival recession (REC), and probing pocket depths (PD), the subjects will be randomized into two balanced groups, test group assigned to the Sonicare ProtectiveClean® HX6848/92 with C2 Optimal Plaque Defense head HX9022/10 (electric toothbrush) and control group assigned to the Pierre Fabre Inava 20/100, a reference manual toothbrush. Subjects will be instructed to brush their teeth for one minute under supervision with their assigned toothbrush and a sodium monofluorophosphate (1450 ppm F) toothpaste (elmex® SENSITIVE PROFESSIONAL) with a low level of abrasion to minimize bias due to toothpaste abrasivity. After brushing, they will again be evaluated for primary and secondary outcomes (post-brushing). Subjects will be dismissed from the study site with their assigned toothbrush and toothpaste, and instructed to brush twice daily at home for the next 12 weeks. The subjects will be instructed to brush for two minutes during each tooth brushing. The subjects will report to the study site after 12 weeks of product use, at which time they will be re-evaluated for gingival abrasion, as well as for plaque removal, gingival inflammation, gingival recession and gingival color. Data (photographs and clinical measurements) will be collected, i.e. primary and secondary variables of each patient, by blinded examiners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2021
CompletedFirst Posted
Study publicly available on registry
May 16, 2022
CompletedStudy Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedMay 16, 2022
May 1, 2022
9 months
October 26, 2021
May 11, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of the gingival abrasion (GA): Macro-relief scoring
A first method for the evaluation of gingival abrasion (GA) will consist in a method of macro-relief scoring of gingival tissue as described previously by Perin et al. with skin tissue. This evaluation consists of acquiring macroscopic views of each investigated surface and then classifying them by observers according to a reference groups of defined abrasion intensity. This evaluation scoring, using photo grading technique, allow delayed and blinded scoring, independent of whole-subject appearance, thus decreasing subjectivity (Perin et al., 2000). Five items are evaluted for each picture : erythema, inflammation, bleeding, recession and erosion of the gingiva. All items are scored from 0 to 3, 3 representing the most significant impairment.
90 days
Secondary Outcomes (5)
Comparison of gingival color;
90 days
Presence of plaque -Plaque index, PI
90 days
Presence of inflammation BOP
90 days
Presence and/or amount of gingival recession (REC)
90 days
Probing pocket depth (PD)
90 days
Study Arms (2)
Electric Toothbrush
EXPERIMENTALElectric toothbrush + manufacturer's instructions + professional recommendations + sodium monofluorophosphate (1450 ppm F) toothpaste (elmex® SENSITIVE PROFESSIONAL)
Manual toothbrush
ACTIVE COMPARATORManual toothbrush + manufacturer's instructions + professional recommendations + sodium monofluorophosphate (1450 ppm F) toothpaste (elmex® SENSITIVE PROFESSIONAL)
Interventions
The participants will be invites to brush their teeth twice a day for 3 months using either an electric toothbrush or a mannual toothbrush and low abrasivity toothpaste
Eligibility Criteria
You may qualify if:
- Dentate males and females must be at least 18 years and not more than 75 years of age
- Patient able to understand and sign the informed consent prior to starting the study
- Patient with a minimum of 3 teeth in each of the 4 quadrants and no/or pockets \>4 mm
- Ability and willingness to comply with all study requirements.
You may not qualify if:
- Pregnancy
- Patient with cervical restorations
- Current smoker
- Patient with orthodontic banding
- Patient with oral lesions or periodontal diseases
- Patient who has been deprived of his/her freedom by administrative or legal decision or who is under trusteeship/guardianship
- Patient already using an electric toothbrush
- Patient with conditions or circumstances, which may prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance, or unreliability;
- Patient with non-plaque induced gingival diseases or localized gingival ulceration
- Thin gingival phenotype
- Patients with cardiac pacemakers to prevent any interference between the power toothbrush and the implantable cardiac device.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rothschild Hospital
Paris, France
Study Officials
- PRINCIPAL INVESTIGATOR
Philippe BOUCHARD, Pr Dr
Rothschild Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2021
First Posted
May 16, 2022
Study Start
July 1, 2022
Primary Completion
April 1, 2023
Study Completion
April 1, 2023
Last Updated
May 16, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share